Exactly how pharmaceutical companies develop new products can be something of a mystery. So we'd like to throw some light on the R&D process that we use.
This stage involves registering a medicine or medical device with local regulatory authorities so they can be distributed within that region.
As much as possible we optimise our development plan before we start in terms of things like patient sample sizes and end-points that the regulator will require. We actively identify risks for the regulator and show them our risk mitigation strategies. This can be quite an exhaustive process, but the first customer you have to satisfy is the regulator.
Because we’re not a large multi-national pharmaceutical company, and we have to ensure we spend our R&D budget wisely, we absolutely have to get the process right. And we do.
Please confirm your email and profession to access the professional product information & downloads. AFT Pharmaceuticals will not share this information externally.
Please confirm your email and password to access the licensee product information and downloads. AFT Pharmaceuticals will not share this information externally.
Forgot your password?
AFT Pharmaceuticals Ltd has become aware of an email spam which may contain malware or be an attempt to obtain personal information of recipients. AFT Pharmaceuticals Ltd does not request payment of invoices through email. It is important that you do not click on any links or images contained within the email.
Should you receive this type of email, please delete it immediately, add the sender to a spam or junk emailing list and run anti-virus software. Should you have any concerns please contact AFT. It appears only Australian email addresses are targeted by this spam, as such as have reported its identification to the Australian Competition and Consumer Commission’s Scamwatch. Should you have any concerns please contact Scamwatch (https://www.scamwatch.gov.au/get-help) or AFT Pharmaceuticals Ltd.
As we become aware of developments we will update this notice accordingly. Thank you for your attention and cooperation on this matter.